FDA Approves Cefepime for Use in B. Braun’s Duplex System

The U.S. Food and Drug Administration has approved an application that permits B. Braun Medical to deliver FDA-approved 1-g and 2-g cefepime for Injection USP and Dextrose Injection USP in B. Braun’s DUPLEX Drug Delivery System, according to a B. Braun news release.

Advertisement

Cefepime is used to treat a wide variety of bacterial infections, and the availability of 1-g and 2-g cefepime in the DUPLEX System will allow more accurate administration of cefepime to patients as it can be stored ready-to-use in a container, according to the release.  

The DUPLEX Drug Delivery System is a ready-to-use, two-compartment, flexible IV container that stores pre-measured pharmaceuticals and diluent doses. Healthcare workers administering 1-g or 2g cefepime through DUPLEX simply fold and squeeze the container and shake it to mix the pharmaceuticals and diluent.

Learn more about B. Braun.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.